Is There More Upside For Regeneron At $620?
- Tuesday, July 7, 2020, 7:12
- Market
- Add a comment
Regeneron Pharmaceuticals’ stock (NASDAQ: REGN) has rallied 66% year-to-date to its current level of $622, significantly outperforming the S&P500, which is down 4%, due to a rapid increase in the number Covid-19 cases resulting in heightened fears of an imminent global economic downturn…
About the Author
admin123 has written 23402 stories on this site.
